Medications

Bebtelovimab appears reliable for COVID-19 during Omicron epoch

For high-risk patients with mild-to-moderate COVID-19 during the Omicron epoch, bebtelovimab seems to be a reliable treatment option, according to a study published online Sept. 17 in the Journal of Infectious Diseases.

Alzheimer's disease & dementia

Examining the relationship between weight, gender and dementia

A substantial body of literature has analyzed the potential association between late-life body mass index (BMI) and dementia. Given that there are some data suggesting that estrogen has neuroprotective effects, it is possible ...

Overweight & Obesity

Pediatric obesity is a complex condition with multiple subtypes

Approximately one third of children in the United States are overweight or obese. A study publishing August 4th in PLOS Digital Health by Elizabeth Campbell at Drexel University, Philadelphia, Pennsylvania, United States, ...

Medications

Study shows genotype leads to discontinued, decreased medication

Patients whose race is recorded as Black in their electronic health record (EHR) are more likely to have azathioprine, an immunosuppressant medication, discontinued or its dose reduced because their laboratory results show ...

page 7 from 31